Derek Dubay to Disease Progression
This is a "connection" page, showing publications Derek Dubay has written about Disease Progression.
Connection Strength
0.059
-
Sirolimus in liver transplant recipients with renal dysfunction offers no advantage over low-dose calcineurin inhibitor regimens. Liver Transpl. 2008 May; 14(5):651-9.
Score: 0.059